Monovalent protein-degraders - Insights and future perspectives.

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Targeted protein degradation is a promising therapeutic strategy.
• Proteolysis targeting chimeras (PROTACs) are a well-established method for protein degradation.
• Alternative mechanisms for targeted protein degradation are needed.

Purpose of the Study:

• To review monovalent protein-degraders as an alternative to PROTACs.
• To highlight novel technologies for discovering and developing monovalent protein-degraders.
• To discuss the potential of monovalent protein-degraders in drug discovery.

Main Methods:

• Review of existing literature on monovalent protein-degraders.
• Discussion of new technologies and assays for identifying degradation targets.
• Analysis of mechanisms for selective protein degradation.

Main Results:

• Monovalent protein-degraders achieve target degradation independently of E3 ubiquitin ligase recognition motifs.
• Emerging technologies facilitate the prediction and enablement of selective pathogenic target degradation.
• These approaches offer potential for novel drugs with improved efficacy and tolerability.

Conclusions:

• Monovalent protein-degraders represent a distinct and promising class of therapeutics.
• Advancements in technology are crucial for unlocking the full potential of these molecules.
• Successful development could lead to new drugs with superior therapeutic profiles.